ATE269714T1 - Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen - Google Patents

Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen

Info

Publication number: ATE269714T1
Authority: AT; Austria
Prior art keywords: tcf; prevention; radiation; treatment; induced disorders
Prior art date: 1997-07-14

Application number

AT98112761T

Other languages

English (en)

Inventor

Yoshio Arai

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-14

Filing date

1998-07-09

Publication date

2004-07-15

1998-07-09 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE269714T1 publication Critical patent/ATE269714T1/de

Links

230000002265 prevention Effects 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
108010094028 Prothrombin Proteins 0.000 abstract 1
208000019095 Radiation-induced disease Diseases 0.000 abstract 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT98112761T 1997-07-14 1998-07-09 Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen ATE269714T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP9188384A JPH1129493A (ja)	1997-07-14	1997-07-14	放射線障害予防及び／又は治療剤

Publications (1)

Publication Number	Publication Date
ATE269714T1 true ATE269714T1 (de)	2004-07-15

Family

ID=16222690

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98112761T ATE269714T1 (de)	1997-07-14	1998-07-09	Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen

Country Status (11)

Country	Link
US (1)	US5998370A (de)
EP (1)	EP0891778B1 (de)
JP (1)	JPH1129493A (de)
KR (1)	KR100564353B1 (de)
AT (1)	ATE269714T1 (de)
AU (1)	AU732053B2 (de)
CA (1)	CA2242559A1 (de)
DE (1)	DE69824670T2 (de)
DK (1)	DK0891778T3 (de)
ES (1)	ES2219810T3 (de)
ZA (1)	ZA986090B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2206523T3 (es) *	1994-12-27	2004-05-16	Daiichi Pharmaceutical Co., Ltd.	Mutantes de tecf.
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
DK0950416T3 (da) *	1997-03-14	2007-02-26	Daiichi Seiyaku Co	Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ232813A (en) *	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
DE69330960T2 (de) *	1992-07-16	2002-04-11	Snow Brand Milk Products Co., Ltd.	Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil
ES2276409T3 (es) *	1992-07-16	2007-06-16	Daiichi Pharmaceutical Co., Ltd.	Composicion medica que contiene tcf-ii.
DE69310525T2 (de) *	1992-09-16	1997-10-02	Genentech Inc	Schutz gegen leberschäden mit hgf
NZ298141A (en) *	1994-12-27	2000-12-22	Snow Brand Milk Products Co Ltd	Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) *	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
DK0950416T3 (da) *	1997-03-14	2007-02-26	Daiichi Seiyaku Co	Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse

1997
- 1997-07-14 JP JP9188384A patent/JPH1129493A/ja active Pending
1998
- 1998-07-06 AU AU74174/98A patent/AU732053B2/en not_active Ceased
- 1998-07-07 CA CA002242559A patent/CA2242559A1/en not_active Abandoned
- 1998-07-08 KR KR1019980027414A patent/KR100564353B1/ko not_active Expired - Fee Related
- 1998-07-09 DK DK98112761T patent/DK0891778T3/da active
- 1998-07-09 EP EP98112761A patent/EP0891778B1/de not_active Expired - Lifetime
- 1998-07-09 AT AT98112761T patent/ATE269714T1/de not_active IP Right Cessation
- 1998-07-09 ZA ZA986090A patent/ZA986090B/xx unknown
- 1998-07-09 ES ES98112761T patent/ES2219810T3/es not_active Expired - Lifetime
- 1998-07-09 DE DE69824670T patent/DE69824670T2/de not_active Expired - Fee Related
- 1998-07-14 US US09/115,294 patent/US5998370A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69824670T2 (de)	2004-12-09
EP0891778A3 (de)	2000-01-26
JPH1129493A (ja)	1999-02-02
EP0891778A2 (de)	1999-01-20
US5998370A (en)	1999-12-07
DK0891778T3 (da)	2004-08-09
KR19990013676A (ko)	1999-02-25
DE69824670D1 (de)	2004-07-29
ES2219810T3 (es)	2004-12-01
AU7417498A (en)	1999-01-21
ZA986090B (en)	1999-04-20
CA2242559A1 (en)	1999-01-14
KR100564353B1 (ko)	2006-09-18
EP0891778B1 (de)	2004-06-23
AU732053B2 (en)	2001-04-12

Similar Documents

Publication	Publication Date	Title
ATE201138T1 (de)	2001-06-15	Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69836752D1 (de)	2007-02-08	Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
EP1001782A4 (de)	2002-01-30	5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
HU912359D0 (en)	1991-12-30	The use of flupirtine active agents for treating muscle-tension
EP0709090A3 (de)	1996-08-28	Zusammensetzungen zur Behandlung von resistenten Tumoren
ATE411026T1 (de)	2008-10-15	Mittel zur behandlung der alzheimer-krankheit
DE69906671D1 (de)	2003-05-15	Substituierte 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanone, deren Verwendung zur Behandlung von Erkrankungen des zentralen und periphären Nervensystems und diese enthaltende pharmazeutische Zusammensetzungen
DE69924375D1 (de)	2005-04-28	Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE60008143D1 (de)	2004-03-11	Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
DE69526390D1 (de)	2002-05-23	Kugelförmige Aktivkohle zur Behandlung von Stoma-peripherer Entzündung
ATE226947T1 (de)	2002-11-15	2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
DE69523654D1 (de)	2001-12-13	Verwendung von Ascorbyl-gamma-Linolenat und von Ascorbyl-dihomo-gamma-linolenat zur Behandlung von Asthma, Krebs, kardiovaskulären und inflammatorischen Erkrankungen
DE69532066D1 (de)	2003-12-11	Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
BR9914848A (pt)	2001-07-10	Composição e processo para o tratamento de distúrbios da retina externa
DE69710111D1 (de)	2002-03-14	Behandlung und Prophylaxe von Pankreatitis
EA200000242A1 (ru)	2000-08-28	Применение фанхинона для лечения болезни альцгеймера
DE69832722D1 (de)	2006-01-12	L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
DE69735417D1 (de)	2006-05-04	2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
ATE269714T1 (de)	2004-07-15	Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen
DE3679781D1 (de)	1991-07-18	Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE3582935D1 (de)	1991-07-04	Mittel zur behandlung von erkrankungen der venen und des analbereichs.
DK1133296T3 (da)	2003-11-17	Ny terapeutisk anvendelse af nicergolin
RU97115054A (ru)	1999-02-20	Средство для лечения онкологических больных

Legal Events

Date

Code

Title

Description

2005-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0891778

Country of ref document: EP

2009-09-15

EEIH

Change in the person of patent owner

2010-04-15

REN

Ceased due to non-payment of the annual fee